Microbe Profile: Streptomyces formicae KY5: an ANT-ibiotic factory

<i>Streptomyces formicae</i> KY5 was isolated from a <i>Tetraponera penzigi</i> plant-ant nest. It is primarily known for its production of the formicamycins, antibiotics with potent activity against Gram-positive pathogens including methicillin-resistant <i>Staphylococcus aureus</i>, and additionally produces an antifungal compound that inhibits multi-drug-resistant fungal pathogens including <i>Lomentospora prolificans. S. formicae</i> is genetically tractable using CRISPR-Cas9 gene editing, allowing for detailed analysis of the formicamycin biosynthetic gene cluster. AntiSMASH analysis predicts the genome to encode at least 45 secondary metabolite biosynthetic gene clusters, many of which appear to encode novel compounds. Current research efforts are focussing on characterising the regulation of secondary metabolism at a global level in order to switch on pathways that are not typically expressed under standard laboratory conditions with the aim of identifying novel antimicrobials.